HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marina Y Konopleva Selected Research

Marina Y Konopleva Research Topics

Disease

41Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 04/2010
14Neoplasms (Cancer)
01/2024 - 09/2015
6Leukemia
01/2023 - 09/2015
5Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2024 - 06/2012
3Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 03/2017
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2019 - 12/2014
2Cytopenia
01/2022 - 01/2021
2Thrombocytopenia (Thrombopenia)
01/2021 - 01/2021
2Philadelphia Chromosome
01/2020 - 12/2016
2Residual Neoplasm
12/2016 - 12/2014
1Turcot syndrome
03/2024
1Cytokine Release Syndrome
01/2024
1Protein Deficiency
01/2023
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2023
1Disease Progression
12/2022
1Pneumonia (Pneumonitis)
01/2022
1Infections
01/2022
1Autoimmune Diseases (Autoimmune Disease)
12/2021
1Bites and Stings (Sting)
01/2021
1Neutropenia
01/2021
1Primary Myelofibrosis (Myelosclerosis)
01/2021
1Anemia
01/2021
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2020
1Squamous Cell Carcinoma of Head and Neck
03/2017
1Ataxia Telangiectasia (Louis Bar Syndrome)
09/2015
1Hypoxia (Hypoxemia)
02/2011

Drug/Important Bio-Agent (IBA)

24venetoclaxIBA
04/2024 - 02/2017
9DecitabineFDA Link
04/2024 - 01/2021
7Cytarabine (Cytosar-U)FDA LinkGeneric
01/2023 - 04/2010
6Azacitidine (5 Azacytidine)FDA Link
12/2023 - 12/2017
4Proteins (Proteins, Gene)FDA Link
01/2023 - 02/2011
3RG7388IBA
01/2023 - 05/2020
2MethyltransferasesIBA
01/2023 - 01/2023
2Lysine (L-Lysine)FDA Link
01/2023 - 12/2018
2CladribineFDA LinkGeneric
01/2023 - 11/2022
2Immune Checkpoint InhibitorsIBA
01/2022 - 10/2021
2Biomarkers (Surrogate Marker)IBA
12/2021 - 03/2017
2Histones (Histone)IBA
12/2019 - 10/2019
2Histone Deacetylase InhibitorsIBA
12/2017 - 06/2012
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2017 - 12/2016
2Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
06/2012 - 04/2010
1AntigensIBA
01/2024
1CytokinesIBA
01/2024
1cobimetinibIBA
01/2024
1tagraxofuspIBA
12/2023
1Interleukin-3 (Interleukin 3)IBA
12/2023
1Diphtheria ToxinIBA
12/2023
1Interleukin-3 Receptors (Interleukin 3 Receptor)IBA
12/2023
1Programmed Cell Death 1 ReceptorIBA
01/2023
1NivolumabIBA
01/2023
1Hydroxyurea (Hydrea)FDA LinkGeneric
01/2023
1DNA (Deoxyribonucleic Acid)IBA
01/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022
1fms-Like Tyrosine Kinase 3IBA
01/2022
1B-Cell Activating FactorIBA
12/2021
1avelumabIBA
10/2021
1Janus Kinase InhibitorsIBA
01/2021
1AzolesIBA
01/2021
1LCL161IBA
01/2021
1Hemoglobins (Hemoglobin)IBA
01/2021
1CR 6IBA
01/2020
1bcr-abl Fusion ProteinsIBA
01/2020
1Acetyl Coenzyme A (Acetyl-CoA)IBA
12/2019
1AMP-Activated Protein KinasesIBA
12/2019
1ChromatinIBA
12/2019
1Protein Kinases (Protein Kinase)IBA
12/2019
1Glucose (Dextrose)FDA LinkGeneric
12/2019
1Adenosine Monophosphate (AMP)IBA
12/2019
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
10/2019
1SB939 compoundIBA
12/2017
1Cisplatin (Platino)FDA LinkGeneric
03/2017
1Lactic Acid (Lactate)FDA LinkGeneric
03/2017
1Carboplatin (JM8)FDA LinkGeneric
03/2017
1PlatinumIBA
03/2017
1Cytochrome P-450 CYP3AIBA
02/2017
1Antifungal AgentsIBA
02/2017
1Cytochrome P-450 CYP3A InhibitorsIBA
02/2017
1posaconazoleFDA Link
02/2017
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2016
1Vincristine (Oncovin)FDA LinkGeneric
12/2016
1Dasatinib (BMS 354825)FDA Link
12/2016
1ponatinibIBA
12/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2016
1InterferonsIBA
09/2015
1eIF-2 Kinase (eIF 2 Kinase)IBA
09/2015
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
09/2015
1Double-Stranded RNA (RNA, Double Stranded)IBA
09/2015
1MK 2206IBA
04/2014
1VorinostatFDA Link
06/2012
1Chemokine ReceptorsIBA
02/2011
1Sorafenib (BAY 43-9006)FDA Link
04/2010

Therapy/Procedure

20Therapeutics
03/2024 - 04/2010
12Drug Therapy (Chemotherapy)
01/2024 - 03/2017
1Drug Tapering
01/2022
1Cell Transplantation
01/2022
1Induction Chemotherapy
01/2022
1Radiotherapy
01/2020